Clinical trials
Phase 3 Failure to Thrive trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2020 | 1 |
| 2023 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ascendis Pharma Endocrinology Division A/S | 3 |
| Ascendis Pharma A/S | 2 |
| Eli Lilly and Company | 1 |
| Northwell Health | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Failure to Thrive | 7 |
| Endocrine System Diseases | 5 |
| Dwarfism, Pituitary | 4 |
| Pituitary Diseases | 3 |
| Chromosome Disorders | 1 |
| Dwarfism | 1 |
| Growth Disorders | 1 |
| Noonan Syndrome | 1 |
| Sex Chromosome Disorders | 1 |
| Sex Chromosome Disorders of Sex Development | 1 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.